Genetic variants, pathophysiological pathways, and oral anticoagulation in patients with hypertrophic cardiomyopathy and atrial fibrillation

HIGHLIGHTS

• who: Shengnan Wang from the (UNIVERSITY) have published the research: Genetic variants, pathophysiological pathways, and oral anticoagulation in patients with hypertrophic cardiomyopathy and atrial fibrillation, in the Journal: (JOURNAL)

SUMMARY

@@

ACRONYMS

LAY DEFINITIONS

• atrial fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES)
• hypertrophic cardiomyopathy: Hypertrophic cardiomyopathy is a disease in which a portion . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.